Cargando…
The UK Myotonic Dystrophy Patient Registry: facilitating and accelerating clinical research
Myotonic dystrophy type 1 (DM1) is the most frequent muscular dystrophy worldwide with complex, multi-systemic, and progressively worsening symptoms. There is currently no treatment for this inherited disorder and research can be challenging due to the rarity and variability of the disease. The UK M...
Autores principales: | Wood, Libby, Cordts, Isabell, Atalaia, Antonio, Marini-Bettolo, Chiara, Maddison, Paul, Phillips, Margaret, Roberts, Mark, Rogers, Mark, Hammans, Simon, Straub, Volker, Petty, Richard, Orrell, Richard, Monckton, Darren G., Nikolenko, Nikoletta, Jimenez-Moreno, Aura Cecilia, Thompson, Rachel, Hilton-Jones, David, Turner, Chris, Lochmüller, Hanns |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5413526/ https://www.ncbi.nlm.nih.gov/pubmed/28397002 http://dx.doi.org/10.1007/s00415-017-8483-2 |
Ejemplares similares
-
Functional impairment in patients with myotonic dystrophy type 1 can be assessed by an ataxia rating scale (SARA)
por: DiPaolo, Giovanni, et al.
Publicado: (2017) -
Disease burden of myotonic dystrophy type 1
por: Landfeldt, Erik, et al.
Publicado: (2019) -
Analysis of the functional capacity outcome measures for myotonic dystrophy
por: Jimenez‐Moreno, Aura Cecilia, et al.
Publicado: (2019) -
Reproductive Cancer Risk Factors in Women With Myotonic Dystrophy (DM): Survey Data From the US and UK DM Registries
por: Higgs, Cecilia, et al.
Publicado: (2019) -
Analyzing walking speeds with ankle and wrist worn accelerometers in a cohort with myotonic dystrophy
por: Jimenez-Moreno, Aura Cecilia, et al.
Publicado: (2018)